No Picture
News

Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Additional VK2809 Phase 2 Data to be Presented at EASL 2019; Results Demonstrate Promising Efficacy at Doses as Low as 5 mg Daily- Initiation of Phase 2b Study of VK2809 in Biopsy-Confirmed NASH Planned… […]

No Picture
News

Biocept’s Liquid Biopsy Test for ESR1 Biomarker Detection to be Featured in Poster Presentation at the 2019 AACR Annual Meeting

Analytical validation of liquid biopsy test for ESR1 mutations offers potential clinical utility by identifying biomarkers that may drive acquired resistance to hormone therapy in breast cancer

SAN DIEGO, March 4, 2019 /PRNewswire/ — Biocept, Inc. (… […]

No Picture
News

Trovagene to Present Data from Lead Clinical Programs of Onvansertib in AML and mCRPC at the American Association for Cancer Research Annual Meeting

SAN DIEGO, Feb. 28, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lympho… […]

No Picture
News

BioAtla Presents CAB-CTLA-4 And CAB-EpCAM-ADC Data At The American Association For Cancer Research Annual Meeting

Oral presentation highlights CAB-CTLA-4 pre-clinical data demonstrating expected efficacy and reduced immune side effects and toxicities as monotherapy or in combination with PD-1 inhibitorsPoster presentation of CAB-EpCAM-ADC demonstrating anti-tumor … […]

No Picture
News

Heron Therapeutics to Present at the 8th Annual Leerink Partners Global Healthcare Conference

SAN DIEGO, Feb. 20, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet … […]

No Picture
News

Phoenix Molecular Designs to Present at BIOCOM’s 2019 Global Life Science Partnering Conference

VANCOUVER, British Columbia and SAN DIEGO, Feb. 20, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today that Dr. San… […]